Brown, Lisle/Cummings, Inc. Boston Scientific Corp Transaction History
Brown, Lisle/Cummings, Inc.
- $329 Billion
- Q3 2024
A detailed history of Brown, Lisle/Cummings, Inc. transactions in Boston Scientific Corp stock. As of the latest transaction made, Brown, Lisle/Cummings, Inc. holds 73,692 shares of BSX stock, worth $6.19 Million. This represents 1.88% of its overall portfolio holdings.
Number of Shares
73,692
Previous 73,617
0.1%
Holding current value
$6.19 Million
Previous $5.67 Billion
8.93%
% of portfolio
1.88%
Previous 1.85%
Shares
12 transactions
Others Institutions Holding BSX
# of Institutions
1,472Shares Held
1.21BCall Options Held
8.13MPut Options Held
8.41M-
Vanguard Group Inc Valley Forge, PA130MShares$10.9 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY126MShares$10.6 Billion0.22% of portfolio
-
State Street Corp Boston, MA61.5MShares$5.16 Billion0.21% of portfolio
-
Primecap Management CO Pasadena, CA38MShares$3.19 Billion2.15% of portfolio
-
Wellington Management Group LLP Boston, MA32.1MShares$2.7 Billion0.45% of portfolio
About BOSTON SCIENTIFIC CORP
- Ticker BSX
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,431,609,984
- Market Cap $120B
- Description
- Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...